Literature DB >> 24758234

Entanglement model of antibody viscosity.

Jeremy D Schmit1, Feng He, Shradha Mishra, Randal R Ketchem, Christopher E Woods, Bruce A Kerwin.   

Abstract

Antibody solutions are typically much more viscous than solutions of globular proteins at equivalent volume fraction. Here we propose that this is due to molecular entanglements that are caused by the elongated shape and intrinsic flexibility of antibody molecules. We present a simple theory in which the antibodies are modeled as linear polymers that can grow via reversible bonds between the antigen binding domains. This mechanism explains the observation that relatively subtle changes to the interparticle interaction can lead to large changes in the viscosity. The theory explains the presence of distinct power law regimes in the concentration dependence of the viscosity as well as the correlation between the viscosity and the charge on the variable domain in our antistreptavidin IgG1 model system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24758234     DOI: 10.1021/jp500434b

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  11 in total

1.  Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors:  Ashlesha S Raut; Devendra S Kalonia
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

2.  In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.

Authors:  Vikas K Sharma; Thomas W Patapoff; Bruce Kabakoff; Satyan Pai; Eric Hilario; Boyan Zhang; Charlene Li; Oleg Borisov; Robert F Kelley; Ilya Chorny; Joe Z Zhou; Ken A Dill; Trevor E Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

3.  Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies.

Authors:  Chaitanya Sudrik; Theresa Cloutier; Phuong Pham; Hardeep S Samra; Bernhardt L Trout
Journal:  MAbs       Date:  2017-07-31       Impact factor: 5.857

4.  Predicting Protein-Protein Interactions of Concentrated Antibody Solutions Using Dilute Solution Data and Coarse-Grained Molecular Models.

Authors:  Cesar Calero-Rubio; Ranendu Ghosh; Atul Saluja; Christopher J Roberts
Journal:  J Pharm Sci       Date:  2017-12-21       Impact factor: 3.534

5.  Cluster Formation and Entanglement in the Rheology of Antibody Solutions.

Authors:  Nelson Ramallo; Subhash Paudel; Jeremy Schmit
Journal:  J Phys Chem B       Date:  2019-04-25       Impact factor: 2.991

Review 6.  Protein aggregation and its impact on product quality.

Authors:  Christopher J Roberts
Journal:  Curr Opin Biotechnol       Date:  2014-08-28       Impact factor: 9.740

7.  Theory for the Liquid-Liquid Phase Separation in Aqueous Antibody Solutions.

Authors:  Miha Kastelic; Vojko Vlachy
Journal:  J Phys Chem B       Date:  2018-01-27       Impact factor: 2.991

Review 8.  The Protein Folding Problem: The Role of Theory.

Authors:  Roy Nassar; Gregory L Dignon; Rostam M Razban; Ken A Dill
Journal:  J Mol Biol       Date:  2021-07-03       Impact factor: 6.151

9.  Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection.

Authors:  Alexandra Lavoisier; Jean-Marc Schlaeppi
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 10.  Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods.

Authors:  Emily K Makowski; Lina Wu; Priyanka Gupta; Peter M Tessier
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.